Drug Enforcement D-1139-2023

Defective Container: slow leakage under the cap

Status

Terminated

Classification

Class III

Report Date

September 6, 2023

Termination Date

August 6, 2025

Product Information

Product description
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60
Product quantity
11,350 bottles
Reason for recall
Defective Container: slow leakage under the cap
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA.

Location & Firm

Recalling firm
Contract Pharmaceuticals Limited Canada
Address
7600 East Danbro Cres, N/A

Canada
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-1139-2023
Event ID
92922
Recall initiation date
August 23, 2023
Center classification date
August 29, 2023
Code info
Lot # 118920, exp. January 2024.
More code info
—